Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.
Jeffrey Gosin

Dr. Jeffrey Gosin M.D.

Attending Surgeon and Chief of Vascular Surgery, SHORE MEMORIAL HOSPITAL

What is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Member of the Healthcare Council

Council Member Biography

Jeffrey Gosin, MD, is a Physician and Vice President at Jersey Shore Surgical Group in New Jersey, since July 1997. Dr. Gosin is also an Attending Surgeon and Chief of Vascular Surgery at Shore Memorial Hospital. He also serves as a Medical Director of the Cardiovascular Institute, a multidisciplinary department which includes vascular surgeons, interventional radiologists, and interventional cardiologists. Dr. Gosin's clinical practice includes most areas of vascular and general surgery. His areas of special interests are minimally-invasive interventional techniques; new technology in surgery; and treatment of carotid artery disease, peripheral arterial occlusive disease, and abdominal aortic aneurysms. Dr. Gosin developed and actively participates in a busy outpatient vein treatment center which specializes in minimally invasive treatment of varicose veins and venous insufficiency. (This is me - Update Profile)


Employment History

2004 - Unspecified
Attending Surgeon and Chief of Vascular Surgery, SHORE MEMORIAL HOSPITAL
1997 - Unspecified
Vascular and General Surgeon, JERSEY SHORE SURGICAL GROUP, P.C.
1997 - Unspecified
Physician and Vice President, JERSEY SHORE SURGICAL GROUP, P.C.

GLG NewsSM Analyses by Jeffrey Gosin(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.

Cook Vena Caval Filter Sets Standard for Retrievable Filters

April 9, 2007

Breakthrough Clinical Results Reveal Extended Retrieval Times for Cook Medical's Gunther Tulip(TM) Vena Cava Filter | salesandmarketingnetwork.com

New data from Cook shows 94% success rate in retrieving a temporary vena caval filter at 12 weeks post implant. This new data confirms what many of us have believed; that retrievable filters can successfully and safely be removed months after implantation.

Leading institutions connect with Jeffrey Gosin through GLG

GLG Live Meetings with Jeffrey Gosin(?)

Jeffrey Gosin has not participated in any GLG Live Meetings.

View all GLG Live Meetings in Healthcare